Abstract
This systematic review and meta-analysis evaluated the efficacy and safety of roflumilast cream in treating atopic dermatitis (AD) by analysing data from three randomised controlled trials. The results demonstrated significant improvement in treatment success with roflumilast compared to vehicle creams, with a modest increase in mild adverse events, supporting its potential as an effective and well-tolerated treatment for AD.
Original language | English |
---|---|
Number of pages | 5 |
Journal | Australasian Journal of Dermatology |
Early online date | 25 Mar 2025 |
DOIs | |
Publication status | E-pub ahead of print - 25 Mar 2025 |